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We have assessed the effects of glutamine (Gin) availability on protein breakdown in perfused rat hindlimb by measuring 
net phenylalanine (Phe) production (an index of protein balance), the dilution of PSN)Phe labelling (an index of mixed 
protein breakdown) and rate of production of 3-methylhistidine (3-MeH) (an index of myofibrillar breakdown). 15 mM 
Gln significantly inhibited net protein loss and protein breakdown compared to rates obtained in its absence (net protein 
loss, 200 f 230 vs 2080 f 200 nmol Phe/hindlimb per h; protein breakdown, 4566 k480 vs 1614+ 180 nmol Phe/hindlimb 
per h; both p<O.Ol). Insulin (100 flu/ml) inhibited protein breakdown but less than Gln. The effects on protein break- 
down of Gln and insulin together were not additive, suggesting acommon mode of action. Production of 3-MeH (mean 
20.3 f 2.8 nmol/hindlimb per h) was unaffected by Gln or insulin. Gln appears to inhibit protein breakdown of soluble 
rather than myofibrillar protein in muscle. 
Glutamine; Anabohsm; Myofibrillar protein; Soluble protein; (Muscle) 
1. INTRODUCTION 
It is now well recognised that wasting of the 
musculature often accompanies bodily injury 
(whether due to elective surgery or accidental in- 
jury), endocrine disease, sepsis, primary myopathy 
and cancer [l]. In such conditions a common 
finding is a lower-than-normal concentration of 
free Gln in the intramuscular water [ 1,2]. We have 
presented evidence elsewhere [3,4] that the 
characteristics of transport of Gln in skeletal mus- 
cle are such (sodium dependency and hormonal 
sensitivity) that known changes in the hormonal 
and ionic milieu occurring with disease and injury 
will tend to promote Gln efflux from muscle. In at- 
tempting to decide whether the correlation between 
low intramuscular Gln concentration and net pro- 
tein wasting of muscle was fortuitous or causal, we 
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discovered a positive relationship between the frac- 
tional rate of muscle protein synthesis and the in- 
tramuscular Gln concentration, manipulated by 
varying the availability of Gln in the perfused rat 
hindlimb preparation [5]. The effect was substan- 
tial, comprising a 2-fold change in muscle protein 
synthesis over the range of intramuscular Gln of 
7-35 pmol/g protein (about 2-12 mM in the in- 
tracellular water). Although the effect was in- 
dependent of insulin (i.e. occurred in its absence), 
the sensitivity of protein synthesis to Gln was 
greater in the presence of high physiological con- 
centrations of insulin (100 pU/ml). Since the 
maintenance of the protein mass of a tissue 
depends on the balance .between rates of protein 
synthesis and breakdown, we were naturally in- 
terested to determine whether the anabolic effect of 
Gln on protein synthesis might extend to an inhibi- 
tion of protein breakdown in the perfused rat mus- 
cle preparation. An inhibitory effect of Gln on pro- 
tein breakdown has been reported for cultured 
muscle cells [6]. 
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appearance into the perfusate of unlabelled Phe 
and 3-MeH as indices of net protein loss and 
myofibrillar protein breakdown, respectively (Phc 
is a constituent of all protein, and may be recycled 
into synthesis; 3-MeH is a constituent of actin and 
myosin only and is not reutilised) and (ii) the rate 
of dilution of the labelling of [15N]Phe during the 
course of the perfusion (an indication of mixed 
protein breakdown). 
2. MATERIALS AND METHODS 
Post-absorptive female Wistar rats (250 f 15 g body wt) were 
studied between 08:30 and 16:00 h, having had free access to 
food and water on the previous night. The rats were anaesthe- 
tised using pentobarbital (Sagatal, May & Baker, Dagenham, 
Essex; 6 mg/lOO g body weight i.p.) before surgical preparation 
for perfusion of the hindquarters in the manner described by 
Ruderman et al. [7]. The perfusion apparatus was as described 
by MacLennan et al. [5]. The perfusate consisted of Krebs- 
Henseleit bicarbonate buffer, pH 7.4, equilibrated with 95% 
OJ5Vo CO2 to which were added sufficient “N-1abelled Phe 
(99% “N, Tracer Technology, Somerville, MA) to bring the in- 
itial perfusate Phe enrichment to 7-8 gatom% excess (APE). All 
other amino acids (except the branched-chain amino acids 
(BCAA) which were at one third of normal plasma concentra- 
tions, Gln which was either absent or present at 15 mM and 
3-MeH which was absent) were present at normal rat plasma 
concentrations [5]. Such manipulations result in intracellular 
Gln concentration in gastrocnemius muscle of about 2 and 10 
pmol/g muscle respectively, compared to 4.8 rmol/g muscle in 
gastrocnemius muscle sampled in vivo from anaesthetised rats. 
In addition [I-“C]Leu (99% [“C]Leu, Tracer Technology) 
was added to the perfusate to approx. 10 APE. After initiation 
of the perfusion at a flow rate of 6 ml/hindquarter per min, the 
preparation was allowed to stabilize over a period of 20 min at 
the end of which gastrocnemius muscle from the left leg was par- 
tially dissected free (blood supply intact) and clamp-frozen us- 
ing Wollenberger tongs cooled in liquid Nz. The left iliac artery 
and vein were ligatured and the flow rate of the right half of the 
hindquarter reduced to 3 ml/min. During the equilibration 
period, the perfusate was discarded, but over the subsequent 40 
min of perfusion, perfusate was collected. Each aliquot was 
thoroughly mixed and samples taken for measurement of amino 
acid concentration (by use of a standard amino acid analyser 
(Biotronik) using lithium buffers and fluorimetric detection), 
and for gas chromatographic-mass pectrometric analysis of 
enrichment of the Phe with “N and Leu with “C [8]. Dp-3-MeH 
(Tracer Technology) was added to the perfusate as internal stan- 
dard (4.5 rmol99% Da). The concentration of 3-MeH in 20-ml 
aliquots of perfusate was measured after precipitating out per- 
fusate albumin using 10% perchloric acid, neutralising with 2 M 
KOH, 0.5 M KC1 desalting was performed by means of ion- 
exchange chromatography using Dowex-SOW X8 (H+ form), by 
washing with 1 M HCI then distilled water. The amino acid frac- 
tion was eluted with 4 M NHdOH, the ammonia evaporated 
under nitrogen and then freeze-dried. The residue was dissolved 
in 0.1 M pyridine then passed through Dowex-SOW X8 (H’) ac- 
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cording to Haverberg et al. [9]. The column was prewetted with 
0.2 M pyridine. Neutral and acidic amino acids were eluted with 
0.2 M pyridine (16 ml) and elution of 3-MeH was achieved using 
1 M pyridine (8 ml). The eluate was concentrated by rotary 
evaporation prior to quantitation of 3-MeH using selected ion 
monitoring GUMS of the tert-butyldimethylsilyl derivative [8]. 
Chromatographic separation was performed on an RSL-300 
fused silica capillary column (25 mx0.25 mm Alltech 
Associates, Deerfield, IL) coupled directly to the ion source of 
a Finnigan 1020B GCMS. Helium was used as a carrier gas; 
sample injection was in the spitless mode. The column was held 
at 140°C for 1 min then ramped to 280°C at 20°C per min. 
The difference in concentrations of amino acids and the 
enrichment of Phe were used to calculate various indices of pro- 
tein turnover by comparison of these values in an aliquot col- 
lected between 40 and 60 min perfusion with those of the first 
aliquot collected between 0 and 20 min perfusion. Net protein 
loss was calculated from the increase in Phe production, 
myofibrillar protein breakdown from the production of 3-MeH 
and the rate of mixed protein breakdown from the dilution of 
[“NIPhe by unlabelled Phe entering the perfusate. The changes 
in [“C]Leu enrichment were used for comparison although it 
was recognised that since Leu may be metabolised to its keto 
acid, the dilution of [13C]Leu would not provide a specific index 
of protein breakdown. At the end of 1 h perfusion, the 
gastrocnemius muscle of the right leg was clamped frozen as the 
left leg had been earlier. Muscle tissues were analyzed for ATP 
and lactate by standard enzymatic methods [lo]; free amino 
acids were extracted from the tissue using 10% perchloric acid. 
Concentrations of muscle free amino acids and enrichments of 
Phe with “N and Leu with “C were estimated as described 
above. Concentrations of intramuscular 3-MeH were not 
measured. 
3. RESULTS 
The perfused preparation was stable throughout 
the 1 h perfusion following the equilibration 
period. Oxygen consumption and production of 
CO2 and H+ were constant and of the expected 
magnitude (305+35, 21&X+28, 2.6-t 1.1 nmol/ 
hindlimb per min, respectively, means -t SD). 
Muscle ATP and lactate concentrations were iden- 
tical in muscle sampled after the initial equilibra- 
tion periods and after 1 h perfusion and were 
similar to values in vivo (36k 9 and 9rt4 pmol/g 
protein, respectively). Intramuscular concentra- 
tions of Gln were, in the absence of added per- 
fusate Gln, 16.5 f 3.5 pmol/g protein, and in the 
presence of 15 mM Gln, 62.4* 8.8pmol/g protein. 
Muscle Glu concentrations (14.4 + 2.8 pmol/g pro- 
tein) were not significantly different, in the absence 
or presence of Gln. There were no significant dif- 
ferences in the intramuscular concentrations of 
Val, Iso and Leu (0.62+0.19, 0.35t-0.10, 
0.53 + 0.13 rmol/g protein, respectively), the 
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Effect of Gln on indices of muscle protein breakdown and net loss of protein 
?erfusate conditions Intramuscular Pbe Net Phe release Mixed protein break- 3-Methylhistidine 
(nmol/g protein) (nmol Phe/hindlimb per h) down (nmol Phe/hind- release (nmol 3-MeH/ 
limb per h) hindlimb per h) 
) Gln, 0 Ins 640 + 170 2080 * 200 4566 + 480 19.1 + 4.8 
15 mM Gln, 0 Ins 570 * 70 200 + 230b 1614 f 180b 24.6 LIZ 8.4 
1 Gln, lOO&/ml Ins 590* 90 1840 + 175 3232 f 340” 18.6 f 2.4 
15 mM Gln, 100 pU/ml Ins 450 f 140” 720 f 140b 1661 f 150s 18.8 + 2.8 
Hindlimbs from 250 f 15 g rats were perfused as in [5] with all perfusate AA except glutamine (0 or 15 mM), BCAA (l/3 normal) and 
3-methylhistidine (absent) at plasma concentrations. [“NIPbe was added to give starting enrichment of 7-8 gatom% excess. Perfusate 
was sampled after 20 min equilibration and again after 60 min; hindlimb muscle was sampled at 60 min. Mixed protein breakdown was 
calculated from the dilution of [i5N]Phe. a p < 0.05; b p < 0.01 comparison of values with those for 0 Gln, 0 insulin. Results are means 
+ SD for 6 preparations 
BCAA, in preperations studied in the absence or 
presence of 15 mM Gln. 
In the absence of perfusate Gln or insulin, the in- 
tramuscular concentration of Phe became elevated 
(as was tyrosine, not shown) and this was reflected 
in a rise of perfusate Phe concentration (table 1). 
The rise in Phe production rate was used as an in- 
dex of the net balance of protein, i.e. protein 
breakdown minus protein synthesis. The release 
rate observed in the absence of Gln was almost 
completely attenuated by its presence; insulin had a 
smaller effect and their presence together caused 
no significant additional diminution in the net rate 
of appearance of unlabelled Phe. 
Insulin and Gin, when presented separately, 
substantially diminished the dilution of [“NIPhe 
by release of unlabelled phenylalanine (table 1). 
Dilution of [13C]Leu was also diminished; the 
ratio of final to initial [13C]Leu labelling was 
0.68 + 0.09 for preparations without Gln or insulin 
and 0.57 f 0.07 in the presence of Gln and insulin 
(pcO.05). As for the effect of the net appearance 
of Phe, the effect of Gln and insulin together on 
the dilution of lSN was no greater than the effect of 
either alone. The rate of appearance of 3-MeH was 
unaffected by the absence or presence of Gln and 
insulin. 
4. DISCUSSION 
The present results were obtained in a prepara- 
tion of mixed skeletal muscle which was able to 
maintain physiological rates of oxygen consump- 
tion and CO2 production as well as normal concen- 
trations of ATP. Muscle lactate concentration and 
production rate were also within the range which 
we observe in the ‘muscle of anaesthetised rats in 
vivo [ll]. 
The lack of any changes in plasma or perfusate 
Glu or BCAA on addition of Gln at 15 mM sug- 
gests that, as expected from the low activities of 
glutaminase in rat muscle, there is no possibility of 
increased production of BCAA as a result of addi- 
tion of Gln. Thus any effects of Gln on protein 
turnover are independent of changes in BCAA. 
The present results show quite clearly that Gln does 
affect the protein balance of perfused rat muscle as 
indicated by the lower release of Phe in the 
presence of elevated concentrations of Gln, the ef- 
fect being to inhibit the net loss of amino acids. We 
have previously shown that Gln stimulates protein 
synthesis in muscle [5] and a substantial part of the 
inhibition of net loss is presumably via this 
mechanism; nevertheless the only means by which 
Gln could conceivably inhibit the dilution of tracer 
[“NIPhe, as was observed, is by an inhibition of 
muscle protein breakdown. This effect was 
substantial, but was not as great as the effect of 
Gln on net Phe balance suggesting that the stimula- 
tion of protein synthesis, as observed previously 
[5], is more sensitive to Gln than the inhibition of 
protein breakdown. The effects of insulin and Gln 
appeared not to be additive suggesting that they act 
through a common mechanism. The effects of Gln 
and insulin on [13C]Leu dilution supported these 
interpretations. 
Assuming that Phe comprises 4% of muscle pro- 
tein and that each hindlimb, perfused from the iliac 
bifurcation, contains about 8 g muscle comprising 
about 18% protein, then the rate of mixed muscle 
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protein breakdown observed in the absence of Gln 
or insulin is about 20% per day. In the presence of 
Gln and insulin, the rate appears to fall to about 
7% per day. We have previously observed rates of 
muscle protein synthesis in the presence of 15 mM 
Gln in an identical preparation to be about 15% 
per day suggesting that there would be accretion of 
hindlimb muscle of about 54% per day, values 
which may be observed in rats of this size under 
some circumstances in vivo [12]. 
The production rate of 3-MeH was identical 
under all circumstances. This suggested that 
although the effect of high concentrations of Gln 
was to inhibit muscle protein breakdown, the pro- 
tein subject to proteolysis did not include that from 
which 3-MeH is derived, i.e. the actin and myosin 
of the myofibrillar apparatus. These observations 
are thus further examples of a particular kind of 
differential response between the soluble sarco- 
plasmic protein which appears to be susceptible to 
a variety of positive and negative influences on its 
rate of proteolysis and myofibrillar protein which 
is much less susceptible [13- 151. 
The present results are consonant with those ob- 
tained in a different system by Smith who showed 
in a brief report that Gln could inhibit release of 
tracer previously incorporated into protein in 
cultured L6 myoblasts [6]. Further, so far as we 
know, they constitute the first observation of an ef- 
fect of Gln in inhibiting muscle protein breakdown 
in mature mixed-fibred mammalian skeletal mus- 
cle. The demonstration of an inhibitory effect on 
muscle protein breakdown adds further weight to 
the idea derived from the correlation between mus- 
cle protein wasting and low intramuscular Gln con- 
centration as well as the demonstration of a 
positive relationship between muscle Gln and pro- 
tein synthetic rate, that intramuscular Gln concen- 
tration plays an important part in the control of the 
size of the muscle mass. 
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